Kristin Abate, Chief Accounting Officer: Karyopharm Therapeutics KPTI Sell · Filed 01/29

Trade details

Type: Insider sale
Amount: $351.5
Shares · price: 50 sh · $7.03 a share
Held after: 22,622 sh
Stock: Karyopharm Therapeutics KPTI
Person: Kristin AbateChief Accounting Officer
Trade date: 26/01/28
Filed: 26/01/29
Days to filing: 1 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/29~02/27

Kristin Abate's recent trades

Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$504
53 sh
$504
Filed 05/15
Traded 05/14
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$5,260
559 sh
$5,260
Filed 03/03
Traded 03/02
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$1,579
265 sh
$1,579
Filed 01/22
Traded 01/21
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,281
362 sh
$2,281
Filed 25/10/03
Traded 25/10/01
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$148
23 sh
$148
Filed 25/09/16
Traded 25/09/15

Kristin Abate, CAO — sold $352 of Karyopharm Therapeutics KPTI · 0.2% of holdings | Whalegun